VRDN icon

Viridian Therapeutics
VRDN

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$39
168% upside
High target

4 analyst ratings

positive
1  neutral
25%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wedbush
Wedbush
Laura Chico
0% 1-yr VRDN win rate
11 Mar ‘26 1 month ago
RBC Capital
RBC Capital
Lisa Walter
67% 1-yr VRDN win rate
27 Feb ‘26 1 month ago
Needham
Needham
Serge Belanger
60% 1-yr VRDN win rate
4 Feb ‘26 2 months ago
Wells Fargo
Wells Fargo
Derek Archila
3 Feb ‘26 2 months ago